EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines.
EBiSC
banking
biobank
data management
ethics
guidance
iPSC
legal
quality
quality control
repository
reprogramming
Journal
Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300
Informations de publication
Date de publication:
10 08 2021
10 08 2021
Historique:
received:
17
11
2020
revised:
07
07
2021
accepted:
07
07
2021
entrez:
11
8
2021
pubmed:
12
8
2021
medline:
15
3
2022
Statut:
ppublish
Résumé
Disease-relevant human induced pluripotent stem cells (iPSCs) are generated worldwide for research purposes; however, without robust and practical ethical, legal, and quality standards, there is a high risk that their true potential will not be realized. Best practices for tissue procurement, iPSC reprogramming, day-to-day cultivation, quality control, and data management aligned with an ethical and legal framework must be included into daily operations to ensure their promise is maximized. Here we discuss key learning experiences from 7 years of operating the European Bank for induced Pluripotent Stem Cells (EBiSC) and recommend how to incorporate solutions into a daily management framework.
Identifiants
pubmed: 34380020
pii: S2213-6711(21)00375-1
doi: 10.1016/j.stemcr.2021.07.009
pmc: PMC8365092
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1853-1867Informations de copyright
Copyright © 2021 Fraunhofer Institut fû¥r Biomedizinische Technik. Published by Elsevier Inc. All rights reserved.
Références
Stem Cell Res. 2019 Jan;34:101349
pubmed: 30660866
ALTEX. 2020;37(3):490-492
pubmed: 32686838
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Rep Pract Oncol Radiother. 2019 Mar-Apr;24(2):180-187
pubmed: 30820192
Stem Cell Reports. 2018 Jan 9;10(1):1-6
pubmed: 29320760
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Nucleic Acids Res. 2016 Jan 4;44(D1):D757-63
pubmed: 26400179
Cell Stem Cell. 2013 Oct 3;13(4):389-91
pubmed: 24094321
Cell Stem Cell. 2014 Apr 3;14(4):427-30
pubmed: 24702994
Stem Cells Transl Med. 2013 Oct;2(10):727-30
pubmed: 23990574
Science. 2013 Jan 18;339(6117):321-4
pubmed: 23329047
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
J Biomed Sci. 2019 Oct 28;26(1):87
pubmed: 31660969
Comput Struct Biotechnol J. 2019 Nov 29;18:35-44
pubmed: 31890142
Stem Cell Reports. 2018 Aug 14;11(2):485-496
pubmed: 30033087
Nat Biotechnol. 2009 Sep;27(9):815-8
pubmed: 19741635
Br J Cancer. 2014 Sep 9;111(6):1021-46
pubmed: 25117809
Cell Stem Cell. 2011 Apr 8;8(4):357-9
pubmed: 21474098
Forensic Sci Int Genet. 2012 Dec;6(6):819-26
pubmed: 22658771
Stem Cell Res. 2017 Apr;20:105-114
pubmed: 28334554
Int J Med Sci. 2018 Jan 1;15(1):36-45
pubmed: 29333086
Regen Med. 2018 Oct;13(7):859-866
pubmed: 30205750
Regen Med. 2015;10(2 Suppl):1-44
pubmed: 25675265
Regen Med. 2019 Mar;14(3):243-255
pubmed: 30938271
Stem Cell Res. 2019 Dec;41:101581
pubmed: 31812872
Regen Med. 2017 Sep;12(6):693-703
pubmed: 28976812
Biopreserv Biobank. 2018 Feb;16(1):3-6
pubmed: 29393664
Front Med (Lausanne). 2020 Feb 14;7:37
pubmed: 32118021
Cell Stem Cell. 2013 Oct 3;13(4):385-8
pubmed: 24094320
Biores Open Access. 2019 Mar 19;8(1):45-58
pubmed: 30906670
Nat Genet. 2015 Jul;47(7):692-5
pubmed: 26111507
Cell Rep. 2020 May 26;31(8):107689
pubmed: 32460021
Stem Cell Res. 2020 May;45:101773
pubmed: 32252012
Int J Cancer. 2020 Mar 1;146(5):1299-1306
pubmed: 31444973